MUMBAI, India, Jan. 8 -- Intellectual Property India has published a patent application (202511104642 A) filed by Lovely Professional University, Phagwara, Punjab, on Oct. 30, 2025, for 'system for evaluating and improving maternal rsv (respiratory syncytial virus) vaccination programs.'
Inventor(s) include Aman Mittal; Preeti Khurana; Dr. Kailash Chandra Juglan; and Manish Kumar.
The application for the patent was published on Dec. 12, under issue no. 50/2025.
According to the abstract released by the Intellectual Property India: "A system for evaluating and improving maternal RSV (Respiratory Syncytial Virus) vaccination programs, comprising a data collection module 101 to collect quantitative data via structured questionnaires from antenatal and lactating mothers regarding RSV awareness, vaccine acceptance, and sociocultural factors, a provider input module 102 to capture qualitative data from healthcare providers related to perceived barriers and facilitators to maternal RSV vaccination, a demographic analysis module 103 to analyze associations between participant demographics, including parity and education level, and vaccine awareness or acceptance, an information source tracking module 104 to identify primary health information channels used by participants, a vaccine delivery preference module 105 to determine preferred vaccination administration methods and settings and a recommendation engine 106 to generate context-specific strategies for improving vaccine uptake, including integration into antenatal care services, healthcare provider-led education, and cold chain infrastructure improvements."
Disclaimer: Curated by HT Syndication.
